NDC 0002-8870 – Omvoh
Mirikizumab 100 mg/mL · Injection, Solution · Subcutaneous
Product NDC0002-8870
Product details
- Brand name
- Omvoh
- Generic name
- Mirikizumab-mrkz
- Labeler
- Eli Lilly and Company
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761279
- Marketed since
- April 29, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-23 Antagonist
Active ingredients
- Mirikizumab 100 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0002-8870-27 | 2 SYRINGE in 1 CARTON (0002-8870-27) / 1 mL in 1 SYRINGE (0002-8870-01) | Apr 29, 2024 |
Other Omvoh products
- 0002-1442 Mirikizumab 100 mg/mL · Injection, Solution · Eli Lilly and Company
- 0002-3116 Mirikizumab 100 mg/mL · Injection, Solution · Eli Lilly and Company
- 0002-7575 Mirikizumab 20 mg/mL · Injection, Solution · Eli Lilly and Company
- 0002-8011 Mirikizumab 100 mg/mL · Injection, Solution · Eli Lilly and Company
- 0002-7717 · Kit · Eli Lilly and Company
- 0002-7722 · Kit · Eli Lilly and Company